Understanding Gonococcal Arthritis Epidemiology
Epidemiology of Gonococcal Arthritis
This study looks at the patterns and causes of gonococcal arthritis over the last ten years to see what factors might increase the risk and to understand the different strains of the bacteria involved.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 11 (estimated) |
| Sex | All |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 2 sites (Rennes, Brittany Region and 1 other locations) |
| Trial ID | NCT06897943 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the epidemiology of Neisseria gonorrhoeae septic arthritis over the past decade at Brest and Rennes university hospitals. It focuses on identifying risk factors associated with the condition by examining clinical and epidemiological data. Additionally, the study seeks to characterize the gonococcal strains to determine the presence of common clones, virulence factors, or specific resistance genes.
Who should consider this trial
Good fit: Ideal candidates include patients with a Neisseria gonorrhoeae-positive joint sample collected between 2014 and 2024.
Not a fit: Patients with a Neisseria gonorrhoeae-negative joint sample or those who oppose participation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of gonococcal arthritis, leading to improved prevention and treatment strategies.
How similar studies have performed: While this study focuses on a specific epidemiological aspect, similar studies have shown success in understanding infectious arthritis, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a Neisseria gonorrhoeae-positive joint sample (from an enrichment vial or a native sample) between 2014 and 2024. Exclusion Criteria: * Patients with Neisseria gonorrhoeae-negative joint sample (from enrichment vial or native sample). * Patients who have expressed opposition to inclusion in the study. * Patients under legal protection (guardianship, curatorship, etc.).
Where this trial is running
Rennes, Brittany Region and 1 other locations
- Rennes University Hospital — Rennes, Brittany Region, France (Recruiting)
- CHU de BREST — Brest, France (Recruiting)
Study contacts
- Principal investigator: Geneviève HERY-ARNAUD — CHU de Brest
- Study coordinator: Geneviève HERY-ARNAUD
- Email: genevieve.hery-arnaud@univ-brest.fr
- Phone: 0298145107
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.